Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × HMPL-013 × Clear all

NCT07170982 2025-09-12

Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer

Phase 2 Not yet recruiting

Endometrial Neoplasms